Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Viridian Therapeutics, Inc.\DE (VRDN) Debt Ratio (2016 - 2025)

Viridian Therapeutics, Inc.\DE (VRDN) has 9 years of Debt Ratio data on record, last reported at 0.04 in Q3 2025.

  • For Q3 2025, Debt Ratio rose 36.14% year-over-year to 0.04; the TTM value through Sep 2025 reached 0.04, up 36.14%, while the annual FY2024 figure was 0.03, 32.71% down from the prior year.
  • Debt Ratio reached 0.04 in Q3 2025 per VRDN's latest filing, up from 0.04 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.04 in Q4 2023 and bottomed at 0.03 in Q3 2024.
  • Average Debt Ratio over 3 years is 0.03, with a median of 0.04 recorded in 2024.
  • Peak YoY movement for Debt Ratio: plummeted 32.71% in 2024, then skyrocketed 36.14% in 2025.
  • A 3-year view of Debt Ratio shows it stood at 0.04 in 2023, then tumbled by 32.71% to 0.03 in 2024, then soared by 30.56% to 0.04 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.04 in Q3 2025, 0.04 in Q2 2025, and 0.03 in Q4 2024.